|
|
Prepublished online as a Blood First Edition Paper on August 8, 2002; DOI 10.1182/blood-2002-04-1058.

Submitted April 8, 2002
Accepted July 23, 2002
SH2-containing inostiol phosphatase SHIP-1 transiently translocates to raft domains and modulates CD16-mediated cytotoxicity in human NK cells
Ricciarda Galandrini*, Ilaria Tassi, Gianfranco Mattia, Luisa Lenti, Mario Piccoli, Luigi Frati, and Angela Santoni
Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci Bolognetti, University 'La Sapienza', Rome, Italy
Department of Clinical Biochemistry, Istituto Superiore di Sanita', Rome, Italy
Department of Experimental Medicine and Pathology, Istituto Pasteur-Fondazione Cenci Bolognetti, University 'La Sapienza', Rome, Italy; Istituto Mediterraneo di Neuroscienze 'Neuromed', Pozzilli, Italy
* Corresponding author; email: ricciarda.galandrini{at}uniroma1.it.
Membrane recruitment of the SH2-containing 5' inositol phosphatase (SHIP) 1 is responsible for the inhibitory signals that modulate phosphatidylinositol 3-kinase-dependent (PI3-K) signaling pathways. Here we have investigated the molecular mechanisms underlying SHIP-1 activation and its role in CD16-mediated cytotoxicity. We initially demonstrated that a substantial fraction of SHIP-1-mediated 5' inositol phosphatase activity associates with CD16 zeta chain upon receptor cross-linking. Moreover, CD16 stimulation on human primary NK cells induces the rapid and transient translocation of SHIP-1 in the lipid-enriched plasma membrane microdomains termed rafts, where it associates with tyrosine-phosphorylated zeta chain and shc adaptor protein. As evaluated by confocal microscopy, CD16 engagement by reverse antibody-dependent cellular cytotoxicity (ADCC), rapidly induces SHIP-1 redistribution toward the area of NK cell contact with target cells and its co-distribution with aggregated rafts where CD16 receptor also co-localizes. The functional role of SHIP-1 in the modulation of CD16-induced cytotoxicity was explored in NK cells infected with recombinant vaccinia viruses encoding wild-type or catalytic domain deleted mutant SHIP-1. We found a significant SHIP-1-mediated decrease of CD16-induced cytotoxicity which is strictly dependent on its catalytic activity. These data demonstrate that CD16 engagement on NK cells induces membrane targeting and activation of SHIP-1 which acts as negative regulator of ADCC function.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. V. Kondadasula, J. M. Roda, R. Parihar, J. Yu, A. Lehman, M. A. Caligiuri, S. Tridandapani, R. W. Burry, and W. E. Carson III
Colocalization of the IL-12 receptor and Fc{gamma}RIIIa to natural killer cell lipid rafts leads to activation of ERK and enhanced production of interferon-{gamma}
Blood,
April 15, 2008;
111(8):
4173 - 4183.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tarasenko, H. K. Kole, A. W. Chi, M. M. Mentink-Kane, T. A. Wynn, and S. Bolland
T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses
PNAS,
July 3, 2007;
104(27):
11382 - 11387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Parihar, R. Trotta, J. M. Roda, A. K. Ferketich, S. Tridandapani, M. A. Caligiuri, and W. E. Carson III
Src Homology 2-Containing Inositol 5'-Phosphatase 1 Negatively Regulates IFN-{gamma} Production by Natural Killer Cells Stimulated with Antibody-Coated Tumor Cells and Interleukin-12
Cancer Res.,
October 1, 2005;
65(19):
9099 - 9107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Galandrini, F. Micucci, I. Tassi, M. G. Cifone, B. Cinque, M. Piccoli, L. Frati, and A. Santoni
Arf6: a new player in Fc{gamma}RIIIA lymphocyte-mediated cytotoxicity
Blood,
July 15, 2005;
106(2):
577 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Trotta, R. Parihar, J. Yu, B. Becknell, J. Allard II, J. Wen, W. Ding, H. Mao, S. Tridandapani, W. E. Carson, et al.
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation
Blood,
April 15, 2005;
105(8):
3011 - 3018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. I. Bonaparte and E. Barker
Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules
Blood,
October 1, 2004;
104(7):
2087 - 2094.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|